The Community Oncology Alliance (COA) filed an Amicus Curiae brief with the United States Court of Appeals for the Seventh Circuit warning that contract pharmacies affiliated with pharmacy benefit managers (PBMs) have taken over and mutated the 340B Drug Pricing Program. In addition to diverting 340B discounts from patients in need, lucrative for-profit PBM
Dear Chair Lina M. Khan, Commissioners, and Staff: On behalf of the Board of Directors of the Community Oncology Alliance (“COA”), we are pleased to share information on the United States Federal Trade Commission’s (“FTC”) Solicitation for Public Comments on the Business Practices of Pharmacy Benefit Managers and Their Impact on Independent Pharmacies and
The Honorable Chiquita Brooks-LaSure, Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-4192-P P.O. Box 8013 Baltimore, MD 21244-8013 Re: CY 2023 Medicare Advantage and Part D Proposed Rule (CMS-4192-P) Dear Administrator Brooks-LaSure: On behalf of the Board of Directors of the Community Oncology Alliance (“COA”), we
Executive Summary Over the past year, an alarming trend has emerged in the healthcare context that threatens to disrupt the entire delivery model for a large subset of our nation’s most vulnerable patients – seniors enrolled in the Medicare Part D Program receiving complex medications for live-saving treatments. This trend – unilaterally-imposed by
Dear Administrator Brooks-LaSure:On behalf of the Board of Directors of the Community Oncology Alliance (“COA”), we are writing to request that the Centers for Medicare & Medicaid Services (“CMS”) revise the CY 2023 Medicare Advantage and Part D Proposed Rule (CMS-4192-P) (the “Proposed Rule”) being finalized to address the Pharmacy Benefits Manager (“PBM”) Express Scripts,
There is growing awareness of the problems and pitfalls with Pharmacy Benefit Managers (PBMs) in the United States health care system.
CONTENTS Legislation & Regulatory Action Advocacy & Education National Cancer Treatment Alliance (NCTA) Practice Support, Resources & Initiatives Events & Meetings Research, Publications & Press Releases RESILIENT adj.: able to withstand or quickly recover from difficult conditions
This cross-sectional mixed-methods study of 31 physician organizations affiliated with 22 US health systems found that volume was a component of primary care and specialist compensation for most POs (83.9% and 93.3%, respectively), representing a substantial portion of compensation when included (mean, 68.2% and 73.7%, respectively).
In news that will surprise those that didn't know Uber Health was a thing, the company recently picked up Michael Cantor as its first chief medical officer.
To assess the impact of the Oncology Care Model (OCM), the Community Oncology Alliance (COA) conducted a survey of member practices. The OCM is a federal payment and delivery reform initiative run by the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s (CMMI) oncology. COA launched a major support initiative effort behind the
Resources
Initiatives
EVENTS
Get Involved
© Copyright Community Oncology Alliance | All Rights Reserved | Terms & Conditions | Privacy Policy
